A meta-analysis of anti-vascular endothelial growth factor remedy for macular edema secondary to central retinal vein occlusion.
BACKGROUND: Central retinal vein occlusion (CRVO) associates with severe vision outcome and no proven beneficial treatment. Our meta-analysis intended to appraise the efficacy and safety of anti-vascular endothelial growth factor (anti-VEGF) agents in macular edema (ME) following CRVO. METHODS: Data...
Main Authors: | Peirong Huang, Wenquan Niu, Zhentian Ni, Renzuo Wang, Xiaodong Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3871640?pdf=render |
Similar Items
-
The Major Role of Anti-Vascular Endothelial Growth Factor for Management of Macular Edema Secondary to Retinal Vein Occlusion
by: Hossam Elden Mohamed Ahmed Khalil, et al.
Published: (2021-06-01) -
Subretinal fluid in macular edema secondary to branch retinal vein occlusion
by: Donghyun Jee, et al.
Published: (2024-06-01) -
Prevalence of Serous Macular Detachment in Recurrent Macular Edema Secondary to Retinal Vein Occlusion
by: Mehmet Ali Şekeroğlu, et al.
Published: (2022-08-01) -
Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
by: Rajvardhan Azad, et al.
Published: (2012-01-01) -
Dexamethasone implant for refractory macular edema secondary to diabetic retinopathy and retinal vein occlusion
by: Yuan-Yuan Zhong, et al.
Published: (2024-10-01)